Increase in the toxoplasmosis infection is expected to boost the toxoplasmosis treatment drugs market growth. According to World Health Organization (WHO) Estimates of the Global Burden of Foodborne Diseases 2015, estimated that nearly 1 million cases of toxoplasmosis occurs annually in the European region which is caused by contaminated food. World Health Organization stated that persons with compromised immune systems are at a higher risk of developing a toxoplasmosis infection.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/4166
Growing incidence of cancer cases is expected to cause toxoplasmosis and, thus, drive the demand for toxoplasmosis treatment drugs market. For instance, according to the American Cancer Society 2020, around 178,520 people in the U.S. are estimated to be diagnosed with leukemia, lymphoma, or myeloma in 2020. According to the American Cancer Society, 2017, cancer was the second most common cause of death in the U.S., which accounted for nearly 1 out of every 4 deaths. According to National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer are diagnosed in the U.S., with around 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2024.
Global Toxoplasmosis Treatment Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus disease (COVID-19) has resulted in over 113,820,168 infected individuals worldwide as of 1st March 2020.
COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channel, and by its financial impact on firms and financial markets. Due to lockdowns, several countries such as Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of such drugs from one place to another.
Key players are adopting strategies such as mergers and research collaborations in order to advance the toxoplasmosis research and develop new disease treatments. For instance, in October 2016, Turing Pharmaceuticals announced a sponsored research agreement with the Washington University in St. Louis (WUSL) to investigate novel treatments for toxoplasmosis.
Key Takeaways of the Global Toxoplasmosis Treatment Drugs Market:
- The global toxoplasmosis treatment drugs market is expected to exhibit a CAGR of 4.9% during the forecast period owing to the growing number of toxoplasmosis cases, increasing number of chronic diseases such as cancer, sexually transmitted diseases. According to the study published in the National Center for Biotechnology Information (NCBI), 2018, patients with solid organ tumors treated with chemotherapy had the highest prevalence rate of toxoplasmosis (28%) and also found higher infection rate in males (26%) than females (10%) in the Egyptian cancer population.
- Among route of administration, the oral segment held a dominant position in the toxoplasmosis treatment drugs market in 2019, as majority of generics which are introduced recently are in the form of tablets
- Among distribution channel, hospital pharmacies segment held a dominant position in the toxoplasmosis treatment drugs market in 2019, as majority of the cancer cases, and toxoplamsosis infection are registered at hospitals. Moreover, chemotherapy are majorly executed in hospitals.
- Key players operating in the global toxoplasmosis treatment drugs market are Vyera Pharmaceuticals LLC, Taj Accura Pharmaceuticals Ltd, Mangalam Drugs and Organics Ltd., Cerovene Healthcare PVT LTD, Greenstone LLC, Amneal Pharmaceuticals, Inc., Turing Pharmaceuticals, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd, and Baxter International Inc.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/4166
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Toxoplasmosis Treatment Drugs Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Toxoplasmosis Treatment Drugs Industry Impact
Chapter 2 Global Toxoplasmosis Treatment Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Toxoplasmosis Treatment Drugs (Volume and Value) by Type
2.3 Global Toxoplasmosis Treatment Drugs (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Toxoplasmosis Treatment Drugs Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Toxoplasmosis Treatment Drugs Market Analysis
Chapter 6 East Asia Toxoplasmosis Treatment Drugs Market Analysis
Chapter 7 Europe Toxoplasmosis Treatment Drugs Market Analysis
Chapter 8 South Asia Toxoplasmosis Treatment Drugs Market Analysis
Chapter 9 Southeast Asia Toxoplasmosis Treatment Drugs Market Analysis
Chapter 10 Middle East Toxoplasmosis Treatment Drugs Market Analysis
Chapter 11 Africa Toxoplasmosis Treatment Drugs Market Analysis
Chapter 12 Oceania Toxoplasmosis Treatment Drugs Market Analysis
Chapter 13 South America Toxoplasmosis Treatment Drugs Market Analysis
Chapter 14 Company Profiles and Key Figures in Toxoplasmosis Treatment Drugs Business
Chapter 15 Global Toxoplasmosis Treatment Drugs Market Forecast (2022-2028)
Chapter 16 Conclusions
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/4166
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027